Success Stories: EB1B Petition Approved for Formulations and Process Development Scientist in Oregon in the Field of Pharmaceutics With Only 8 Citations and No PhD
Client’s Testimonial:
Thank you! It’s unbelievable and such a huge surprise and this wouldn’t have been possible without your help.
General Field: Pharmaceutics
Position at the Time of Case Filing: Formulations and Process Development Scientist
Petitioner: A Private Company
Country of Origin: India
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: Oregon
Approval Notice Date: June 7, 2014
Processing Time: 5 months and 19 days
Case Summary:
At North America Immigration Law Group– WeGreened.com, we recently received an EB1B approval for a Formulations and Process Development Scientist in the field of Pharmaceutics. The beneficiary’s outstanding ability, highly skilled background, and impressive record of achievement provided a strong case for his EB1B petition. His specialized research has focused on a discipline of pharmacy that deals with the process of turning new chemical entities (NCE) into medications to be used safely and effectively by patients. His research work had resulted in at least 2 peer-reviewed scholarly articles published in leading journals, 4 Investigative New Drug Applications (IND), 4 conference presentations and proceedings, along with 2 patent applications. Furthermore, the beneficiary had a total of 8 citations to his work by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of his work. The petitioner in this case was a private company. The significance of the beneficiary’s research is confirmed in the following quote by an independent recommender, “I have taken notice of the research of [client] and believe it to be some of the most relevant and important work in the field of pharmaceutical research today. The last decade or so of his work has focused on the development of drug products that positively influence the treatments for diseases such as smallpox, Alzheimer’s, age-related macular degeneration, and epilepsy. This information provides medical researchers a valuable perspective on possible future treatments when it comes to diseases previously mentioned. The wide application of his research makes its continuance beneficial to multiple areas of national and global interest.” It was our goal to prove that this beneficiary qualified for classification as an outstanding professor or researcher given the international recognition for his outstanding achievements. His petition was approved in less than 6 months.

